-
Signature
-
/s/ Howard Diamond, as Attorney-in-fact for Barry L. Biffle
-
Issuer symbol
-
ULCC
-
Transactions as of
-
03 Jan 2025
-
Net transactions value
-
+$306,560
-
Form type
-
4
-
Filing time
-
07 Jan 2025, 16:49:13 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
ULCC |
Common Stock |
Options Exercise |
$783,680 |
+200,000 |
+25% |
$3.92 |
984,817 |
03 Jan 2025 |
Direct |
|
| transaction |
ULCC |
Common Stock |
Options Exercise |
$783,680 |
+200,000 |
+20% |
$3.92 |
1,184,817 |
06 Jan 2025 |
Direct |
|
| transaction |
ULCC |
Common Stock |
Sale |
$1,260,800 |
-160,000 |
-14% |
$7.88 |
1,024,817 |
06 Jan 2025 |
Direct |
F1 |
| holding |
ULCC |
Common Stock |
|
|
|
|
|
48,949 |
03 Jan 2025 |
By Family Trust |
F2 |
| holding |
ULCC |
Common Stock |
|
|
|
|
|
158,975 |
03 Jan 2025 |
By Spouse |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
ULCC |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-200,000 |
-15% |
$0.000000 |
1,164,580 |
03 Jan 2025 |
Common Stock |
200,000 |
$3.92 |
Direct |
F3 |
| transaction |
ULCC |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-200,000 |
-17% |
$0.000000 |
964,580 |
06 Jan 2025 |
Common Stock |
200,000 |
$3.92 |
Direct |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: